Skip to main content
Argonne National Laboratory

COVID-19 Research

The pandemic of the novel coronavirus, SARS-CoV-2, which causes COVID-19, represents one of the greatest challenges of our lifetime.

Scientists at the U.S. Department of Energy’s Argonne National Laboratory have joined forces with research institutions across the nation and around the globe to combat the spread of the COVID-19 pandemic. By using the ultra-bright, high-energy X-rays provided by Argonne’s Advanced Photon Source, they are employing this powerful tool to determine the protein structures of the virus. By understanding the virus’s protein structure, researchers can lay the groundwork for potential drug therapies and vaccines. Through state-of-the-art supercomputing, Argonne researchers are providing insights that may form the foundation of a vaccine. At the same time, other scientists are modeling the further progression of the epidemic and ensuring that supply chains and key infrastructure remain resilient in a time of uncertainty.

Argonne contributes to the National Biodefense Strategy, a single coordinated effort to orchestrate the full range of activities carried out across the United States government to protect the American people.

Argonne is also participating in the COVID-19 High Performance Computing Consortium, which combines the power of 16 different supercomputing systems with expertise from government, academia, and industry.

The U.S. Department of Energy National Virtual Biotechnology Laboratory (NVBL) is a consortium of DOE National laboratories, each with core capabilities relevant to the threats posed by COVID-19. Argonne and its user facilities are active participants in the consortium. The NVBL is taking advantage of DOE user facilities, including light and neutron sources, nanoscale science centers, sequencing and bio-characterization facilities, and high-performance computer facilities, to address key challenges in responding to the COVID-19 threat. 

The laboratory’s work fighting COVID-19 is attracting national attention. This site includes stories from Argonne and other outlets that detail our varied efforts in the ongoing battle against this fearsome disease.